{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:13:28Z","timestamp":1724843608475},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T00:00:00Z","timestamp":1477612800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1945-9","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T13:14:52Z","timestamp":1477660492000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acute HIV infection presenting as hemophagocytic syndrome with an unusual serological and virological response to ART"],"prefix":"10.1186","volume":"16","author":[{"given":"Rita Veiga","family":"Ferraz","sequence":"first","affiliation":[]},{"given":"Ana Cl\u00e1udia","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Carmo","family":"Koch","sequence":"additional","affiliation":[]},{"given":"C\u00e2ndida","family":"Abreu","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,10,28]]},"reference":[{"key":"1945_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11904-012-0113-0","volume":"9","author":"M O\u2019Brien","year":"2012","unstructured":"O\u2019Brien M, Markowitz M. Should we treat acute HIV infection? Curr HIV\/AIDS Rep. 2012;9:101\u201310.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1945_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1086\/655655","volume":"202","author":"SK Bell","year":"2010","unstructured":"Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis. 2010;202:278\u201388.","journal-title":"J Infect Dis"},{"key":"1945_CR3","unstructured":"AIDS info 2015. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Available at: \n                    https:\/\/aidsinfo.nih.gov\/guidelines\/html\/4\/adult-and-adolescent-oi-prevention-and-treatment-guidelines\/325\/tb\n                    \n                  . Accessed 7 May 2013."},{"key":"1945_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"1945_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ijid.2011.09.002","volume":"15","author":"C Antonio","year":"2011","unstructured":"Antonio C, Todaro G, Bonina L, IAria C. Letter to the editor: please, do not forget secondary hemophagocytic lymphohistiocytosis in HIV- infected patients. Int J Infect Dis. 2011;15:885\u20136.","journal-title":"Int J Infect Dis"},{"key":"1945_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0248-8663(97)81959-5","volume":"18","author":"L Sailler","year":"1997","unstructured":"Sailler L, Duchayne E, Marchou B, et al. Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients. Rev Med Interne. 1997;18:855\u201364.","journal-title":"Rev Med Interne"},{"key":"1945_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/QAD.0b013e328339e55b","volume":"24","author":"L Fardet","year":"2010","unstructured":"Fardet L, Lambotte O, Meynard JL, et al. Reactive haemophagocytic syndrome in 58 HIV-1 infected patients: clinical features, underlying diseases and prognosis. AIDS. 2010;24:1299\u2013306.","journal-title":"AIDS"},{"key":"1945_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2169\/internalmedicine.52.7544","volume":"52","author":"E Adachi","year":"2013","unstructured":"Adachi E, Koibuchi T, Imai K, et al. Hemophagocytic syndrome in an acute human immunodeficiency virus infection. Intern Med. 2013;52:629\u201332.","journal-title":"Intern Med"},{"key":"1945_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0b013e3282fbd1da","volume":"22","author":"KJ Michael","year":"2008","unstructured":"Michael KJ, Youn HL, Hazelwood JD, et al. Treatment response in acute\/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline. AIDS. 2008;22:957\u201362.","journal-title":"AIDS"},{"issue":"21","key":"1945_CR10","doi-asserted-by":"publisher","first-page":"10200","DOI":"10.1128\/JVI.75.21.10200-10207.2001","volume":"75","author":"D Montefiori","year":"2001","unstructured":"Montefiori D, Hill TS, VO HTT, Walker BD, Rosenberg ES. Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of Acute Human Immunodeficiency Virus Type 1 Infection. J Virol. 2001;75(21):10200\u20137.","journal-title":"J Virol"},{"key":"1945_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1084\/jem.193.2.169","volume":"193","author":"M Altfeld","year":"2001","unstructured":"Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001;193:169\u201380.","journal-title":"J Exp Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1945-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:22:21Z","timestamp":1487722941000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,28]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1945-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,28]]},"article-number":"619"}}